![Robert E. Déziel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert E. Déziel
No más puestos en curso
Historial de carrera de Robert E. Déziel
Antiguos cargos conocidos de Robert E. Déziel.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Neokimia, Inc. | Director Técnico/Científico/I+D | - | - |
Origenix Technologies, Inc. | Director Técnico/Científico/I+D | - | - |
MIRATI THERAPEUTICS | Corporate Officer/Principal | 01/01/2003 | - |
Formación de Robert E. Déziel.
University of Montréal | Doctorate Degree |
Estadísticas
Internacional
Canadá | 4 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Mirati Therapeutics, Inc.
![]() Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Neokimia, Inc. | Health Technology |
Origenix Technologies, Inc. |
- Bolsa de valores
- Insiders
- Robert E. Déziel
- Experiencia